- CSR Summary Not Yet Available
- NCT04068792 Not Available
- Primary Citation Trial has yet to be published
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameRilematovirProduct NameTherapeutic AreaViral DiseasesEnrollment22% Female31.80%%% White4.50%%
Product ClassRSV Fusion InhibitorSponsor Protocol Number53718678RSV2006Data PartnerJohnson & JohnsonCondition StudiedRespiratory Syncytial VirusesMean/Median Age (Years)3.6
Supporting Documentation
- Collected Datasets Available
- Statistical Analysis Plan Available
- Clinical Study Report Available